Market Cap 12.96B
Revenue (ttm) 2.85B
Net Income (ttm) 426.86M
EPS (ttm) N/A
PE Ratio 25.99
Forward PE 20.49
Profit Margin 14.96%
Debt to Equity Ratio 0.00
Volume 1,448,600
Avg Vol 1,526,076
Day's Range N/A - N/A
Shares Out 190.78M
Stochastic %K 2%
Beta 0.30
Analysts Strong Sell
Price Target $97.81

Latest News on BMRN

Why Is BioMarin Stock Trading Higher On Thursday?

Feb 20, 2025, 9:39 AM EST - 5 weeks ago

Why Is BioMarin Stock Trading Higher On Thursday?


BioMarin to Participate in Three Upcoming Investor Conferences

Nov 6, 2024, 8:00 AM EST - 5 months ago

BioMarin to Participate in Three Upcoming Investor Conferences


3 Oversold Stocks with Big RSI Rebound Potential

Oct 8, 2024, 2:42 PM EDT - 6 months ago

3 Oversold Stocks with Big RSI Rebound Potential

ELV HUM


BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time

Sep 4, 2024, 7:30 AM EDT - 7 months ago

BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time


BioMarin to reduce global workforce by about 225 employees

Aug 28, 2024, 5:32 PM EDT - 7 months ago

BioMarin to reduce global workforce by about 225 employees


BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024

Aug 21, 2024, 4:21 PM EDT - 8 months ago

BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024


BioMarin Announces New R&D and Business Development Leadership

Aug 21, 2024, 8:30 AM EDT - 8 months ago

BioMarin Announces New R&D and Business Development Leadership


BioMarin to Host 2024 Investor Day on September 4th in New York

Aug 19, 2024, 9:00 AM EDT - 8 months ago

BioMarin to Host 2024 Investor Day on September 4th in New York